Int J Health Care Finance Econ. 2007 Sep;7(2-3):217-31.

The organization and financing of end-stage renal disease treatment in Japan.

Fukuhara S, Yamazaki C, Hayashino Y, Higashi T, Eichleay MA, Akiba T, Akizawa T, Saito A, Port FK, Kurokawa K.

Source

Department of Epidemiology and Healthcare Research, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan. fukuhara@pbh.med.kyoto-u.ac.jp

Abstract

End-stage renal disease (ESRD) affects 230,000 Japanese, with about 36,000 cases diagnosed each year. Recent increases in ESRD incidence are attributed mainly to increases in diabetes and a rapidly aging population. Renal transplantation is rare in Japan. In private dialysis clinics, the majority of treatment costs are paid as fixed fees per session and the rest are fee for service. Payments for hospital-based dialysis are either fee-for-service or diagnosis-related. Dialysis is widely available, but reimbursement rates have recently been reduced. Clinical outcomes of dialysis are better in Japan than in other countries, but this may change given recent ESRD cost containment policies.

PMID:: 17690980; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review International Study of Health Care Organization and Financing for end-stage renal disease in France. [Int J Health Care Finance Econ...]
Review International Study of Health Care Organization and Financing for end-stage renal disease in France.
Durand-Zaleski I, Combe C, Lang P. Int J Health Care Finance Econ. 2007 Sep; 7(2-3):171-83.
International study of health care organization and financing: development of renal replacement therapy in Germany. [Int J Health Care Finance Econ...]
International study of health care organization and financing: development of renal replacement therapy in Germany.
Kleophas W, Reichel H. Int J Health Care Finance Econ. 2007 Sep; 7(2-3):185-200.
Review Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease. [Int J Health Care Finance Econ...]
Review Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.
Van Biesen W, Lameire N, Peeters P, Vanholder R. Int J Health Care Finance Econ. 2007 Sep; 7(2-3):133-48.
Review International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. [Int J Health Care Finance Econ...]
Review International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
Pontoriero G, Pozzoni P, Vecchio LD, Locatelli F. Int J Health Care Finance Econ. 2007 Sep; 7(2-3):201-15.
Review End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). [Int J Health Care Finance Econ...]
Review End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
Dor A, Pauly MV, Eichleay MA, Held PJ. Int J Health Care Finance Econ. 2007 Sep; 7(2-3):73-111.

See reviews... See all...

Cited by 1 PubMed Central article

Cost-effectiveness of chronic kidney disease mass screening test in Japan. [Clin Exp Nephrol. 2012]
Cost-effectiveness of chronic kidney disease mass screening test in Japan.
Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, Tsuruya K, Yoshida H, Iseki K, Watanabe T. Clin Exp Nephrol. 2012 Apr; 16(2):279-91. Epub 2011 Dec 14.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The organization and financing of end-stage renal disease treatment in Japan.
The organization and financing of end-stage renal disease treatment in Japan.
Int J Health Care Finance Econ. 2007 Sep ;7(2-3):217-31.

PubMed
Genetic support for the dual nature of attention deficit hyperactivity disorder:...
Genetic support for the dual nature of attention deficit hyperactivity disorder: substantial genetic overlap between the inattentive and hyperactive-impulsive components.
J Abnorm Child Psychol. 2007 Dec ;35(6):999-1008. Epub 2007 Aug 10 .

PubMed
Medical expenditures for children with an autism spectrum disorder in a privatel...
Medical expenditures for children with an autism spectrum disorder in a privately insured population.
J Autism Dev Disord. 2008 Mar ;38(3):546-52. Epub 2007 Aug 10 .

PubMed
Collision-induced reporter fragmentations for identification of covalently modif...
Collision-induced reporter fragmentations for identification of covalently modified peptides.
Anal Bioanal Chem. 2007 Oct ;389(4):1003-16. Epub 2007 Aug 10 .

PubMed
[Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
[Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
Hautarzt. 2001 Oct ;52(10):895-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: